2-03-2023, 04:47

Molecular Templates Announces Participation in Upcoming

AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or
Globe Newswire2-03-2023, 04:47
2-03-2023, 04:42

InnovAge Names Christine Bent as Chief Operations Officer

DENVER, March 01, 2023 (GLOBE NEWSWIRE) -- Today, InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry
Globe Newswire2-03-2023, 04:42
2-03-2023, 04:09

Nature’s Sunshine Sets Fourth Quarter and Full Year 2022

LEHI, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nature’s Sunshine) (NASDAQ: NATR), a
Globe Newswire2-03-2023, 04:09
2-03-2023, 04:07

Sana Biotechnology to Present at the Cowen 43rd Annual

[img]https://ml.globenewswire.com/Resource/Download/86b7f0b7-b317-402a-b600-8a26860a948e?size=1[/img]SEATTLE, March 01,
Globe Newswire2-03-2023, 04:07
2-03-2023, 02:49

Warner Music Group Corp. to Participate in Morgan Stanley

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today
Globe Newswire2-03-2023, 02:49
1-03-2023, 21:29

ZyVersa Therapeutics to Participate in a Fireside Chat at

CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux
Globe Newswire1-03-2023, 21:29
1-03-2023, 21:02

NGM Bio to Participate in the Cowen 43rd Annual Health Care

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM),
Globe Newswire1-03-2023, 21:02
1-03-2023, 20:22

Royalty Pharma Appoints Ashwin Pai as Executive Vice

NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of
Globe Newswire1-03-2023, 20:22
1-03-2023, 20:01

BioNTech Announces Establishment of Interdisciplinary mRNA

JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company
Globe Newswire1-03-2023, 20:01
1-03-2023, 19:22

Xometry Reports Fourth Quarter and Full Year 2022 Results

Q4 revenue increased 46% year-over-year driven by solid marketplace growth of 32% as well as supplier services
Globe Newswire1-03-2023, 19:22
1-03-2023, 18:52

Kineta Appoints Internationally-Renowned Clinical

SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire1-03-2023, 18:52
1-03-2023, 18:36

Beam Therapeutics to Participate in the 43rd Annual Cowen

CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company
Globe Newswire1-03-2023, 18:36